Neutrophil α-defensin-1 is present in human stroke thrombi and induces NETosis in vitro
Clinical Scorecard: Presence of Neutrophil α-defensin-1 in Human Stroke Thrombi and Its Role in Inducing NETosis In Vitro
At a Glance
| Category | Detail |
|---|
| Condition | Ischemic Stroke |
| Key Mechanisms | Presence of neutrophil α-defensin-1 and its role in inducing NETosis |
| Target Population | Patients undergoing mechanical thrombectomy for acute ischemic stroke |
| Care Setting | Acute care settings, specifically during mechanical thrombectomy procedures |
Key Highlights
- α-Defensin-1 detected in all analyzed ischemic stroke thrombi
- NETs are prominent in thrombi, contributing to thrombus stability
- In vitro exposure to α-defensin-1 significantly increases NETosis
- α-Defensin-1 co-localizes with neutrophils in stroke thrombi
- Potential link between neutrophil degranulation and thrombus composition
Guideline-Based Recommendations
Diagnosis
- Confirm ischemic stroke via CT angiography
Management
- Mechanical thrombectomy for eligible patients within 6 hours of stroke onset
Monitoring & Follow-up
- Assess thrombus composition and presence of NETs in retrieved thrombi
Risks
- Increased thrombus stability and resistance to fibrinolysis due to NETs
Patient & Prescribing Data
Adult patients presenting with acute ischemic stroke
α-Defensin-1 may influence thrombus formation and stability
Clinical Best Practices
- Consider the role of neutrophil-derived components in thrombus pathology
- Monitor for NET formation in patients with ischemic stroke
- Evaluate the impact of α-defensins on thrombus management strategies
Related Resources & Content
